InvestorsHub Logo
Followers 58
Posts 10154
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 148890

Friday, 04/27/2018 11:46:43 AM

Friday, April 27, 2018 11:46:43 AM

Post# of 462573

I am also expecting a hook up with either Takeda or Eisai for manufacturing and trials and distribution in Asia



Brilliant connection. Of course this will have to be a next step once the fundamental science is clarified/confirmed. Proper analysis of PDD/AD/RS results should elaborate on what works and what does not. Maybe even why. The assessments of this next level solutions is what breaks the bubble. These tools will facilitate immediate scientific analysis.

I am more confident AVXL can/will resolve the scientific problems. In fact at some point the rest of the scientific community will fall in line (see JonJ great posts on how much time it takes for science to win). We should not confuse healthcare industry with science. The galaxy of money and power at stake here (regulatory/political/financial/unknown) is beyond the power of any individual company to comprehend, much less fix. Curiously, the efficacy of the science at AVXL may end up the least of our problems. To me, this explains why we are here and why BIIB is where it is.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News